All News #Library
Rare Diseases
Corcept Submitted Lead Asset For Approval Despite FDA Warning
30 Jan 2026 //
FIERCE BIOTECH
Corcept Faces Teva Lawsuit Over Mifepristone `Monopoly`
15 Sep 2025 //
REUTERS
Teva sues Corcept over mifepristone `monopoly` for rare disorder
14 Jun 2024 //
REUTERS

Market Place
Sourcing Support